Our findings indicate that Fabp3-defect exacerbates cardiac hypertrophy and heart dysfunction, resulting in defective FAO, and increased glycolysis by impairing the PPARα signaling pathway. The gene discussed is FABP3; the disease is cardiac hypertrophy.